Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Atezolizumab + Chemotherapy for Bladder Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is testing a new cancer treatment combining atezolizumab, platinum, and etoposide for patients with locally advanced urothelial cancer. The goal is to see if this new treatment can help patients achieve a pathologic complete response (no cancer cells remaining) at cystectomy (surgery to remove the bladder).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service